DrugPatentWatch's articles Biotechnology CDMO Value Proposition: Why It Matters Copyright © DrugPatentWatch. Originally published at The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the industry continues to evolve, CDMOs must adapt and innovate to meet the changing needs of their clients. In this article, we will explore the importance of the CDMO value […] Written by DrugPatentWatch March 30, 2025March 30, 2025 Saving Bookmark this article Bookmarked Biotechnology Rx for Change: How Nonprofit Pharma is Reshaping the Industry Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ An HHS report titled “The Potential Role of The Nonprofit Pharmaceutical Industry in Addressing Shortages and Increasing Access to Essential Medicines and Low-Cost Medicines” explores the emergence and impact of nonprofit pharmaceutical companies in the U.S. market. It identifies 11 nonprofit pharmaceutical companies launched between 2000 and 2022, […] Written by DrugPatentWatch August 8, 2024August 8, 2024 Saving Bookmark this article Bookmarked Biotechnology The Complexity Advantage: Why Advanced Delivery Methods Deter Generic Competition Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Photo by Luci on Pexels.com In the highly competitive pharmaceutical landscape, adopting complex drug delivery systems can provide a strategic advantage for both branded and generic drug manufacturers. These advanced delivery methods, such as injectables, inhalers, transdermal patches, and specialized formulations, offer numerous benefits that extend beyond the […] Written by DrugPatentWatch July 22, 2024July 22, 2024 Saving Bookmark this article Bookmarked Biotechnology Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma – DrugPatentWatch Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical endpoints in early drug discovery. This platform is accessible to all scientists within the company and has proven […] Written by DrugPatentWatch October 30, 2023October 30, 2023 Saving Bookmark this article Bookmarked
Biotechnology CDMO Value Proposition: Why It Matters Copyright © DrugPatentWatch. Originally published at The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the industry continues to evolve, CDMOs must adapt and innovate to meet the changing needs of their clients. In this article, we will explore the importance of the CDMO value […] Written by DrugPatentWatch March 30, 2025March 30, 2025 Saving Bookmark this article Bookmarked
Biotechnology Rx for Change: How Nonprofit Pharma is Reshaping the Industry Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ An HHS report titled “The Potential Role of The Nonprofit Pharmaceutical Industry in Addressing Shortages and Increasing Access to Essential Medicines and Low-Cost Medicines” explores the emergence and impact of nonprofit pharmaceutical companies in the U.S. market. It identifies 11 nonprofit pharmaceutical companies launched between 2000 and 2022, […] Written by DrugPatentWatch August 8, 2024August 8, 2024 Saving Bookmark this article Bookmarked
Biotechnology The Complexity Advantage: Why Advanced Delivery Methods Deter Generic Competition Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Photo by Luci on Pexels.com In the highly competitive pharmaceutical landscape, adopting complex drug delivery systems can provide a strategic advantage for both branded and generic drug manufacturers. These advanced delivery methods, such as injectables, inhalers, transdermal patches, and specialized formulations, offer numerous benefits that extend beyond the […] Written by DrugPatentWatch July 22, 2024July 22, 2024 Saving Bookmark this article Bookmarked
Biotechnology Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma – DrugPatentWatch Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical endpoints in early drug discovery. This platform is accessible to all scientists within the company and has proven […] Written by DrugPatentWatch October 30, 2023October 30, 2023 Saving Bookmark this article Bookmarked
